Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T L Liu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Eye (London, England)|September 27, 2014
Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcomeM Ho, E C F Lo, A L Young, et al.
The British Journal of Ophthalmology|September 20, 2008
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot studyW-M Chan, T Y Y Lai, D T L Liu, et al.
The British Journal of Ophthalmology|October 20, 2005
Choroidal neovascularisation in pathological myopia: an update in managementW-M Chan, M Ohji, T Y Y Lai, et al.
The British Journal of Ophthalmology|March 22, 2008
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathyT Y Y Lai, W-M Chan, D T L Liu, et al.
The British Journal of Ophthalmology|February 21, 2006
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative studyW-M Chan, T Y Y Lai, A L Wong, et al.
Eye (London, England)|September 18, 2004
Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective seriesD S C Lam, D T L Liu, D S P Fan, et al.
The British Journal of Ophthalmology|April 7, 2006
Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot studyT Y Y Lai, W-M Chan, H Li, et al.
The British Journal of Ophthalmology|September 21, 2004
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow upD S C Lam, W-M Chan, D T L Liu, et al.
The British Journal of Ophthalmology|December 9, 2003
Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease levelW-M Chan, D S C Lam, T Y Y Lai, et al.
European Journal of Ophthalmology|July 9, 2008
Vigabatrin-induced visual dysfunction in Chinese patients with refractory epilepsyA C F Hui, D T L Liu, K K Wong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Eye (London, England)|September 27, 2014
Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcomeM Ho, E C F Lo, A L Young, et al.
The British Journal of Ophthalmology|September 20, 2008
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot studyW-M Chan, T Y Y Lai, D T L Liu, et al.
The British Journal of Ophthalmology|October 20, 2005
Choroidal neovascularisation in pathological myopia: an update in managementW-M Chan, M Ohji, T Y Y Lai, et al.
The British Journal of Ophthalmology|March 22, 2008
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathyT Y Y Lai, W-M Chan, D T L Liu, et al.
The British Journal of Ophthalmology|February 21, 2006
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative studyW-M Chan, T Y Y Lai, A L Wong, et al.
Eye (London, England)|September 18, 2004
Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective seriesD S C Lam, D T L Liu, D S P Fan, et al.
The British Journal of Ophthalmology|April 7, 2006
Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot studyT Y Y Lai, W-M Chan, H Li, et al.
The British Journal of Ophthalmology|September 21, 2004
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow upD S C Lam, W-M Chan, D T L Liu, et al.
The British Journal of Ophthalmology|December 9, 2003
Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease levelW-M Chan, D S C Lam, T Y Y Lai, et al.
European Journal of Ophthalmology|July 9, 2008
Vigabatrin-induced visual dysfunction in Chinese patients with refractory epilepsyA C F Hui, D T L Liu, K K Wong, et al.
Pageof 2